Archive for July 3rd, 2009

SKorea to buy vaccine for quarter of population (AFP)

Friday, July 3rd, 2009

AFP – South Korea’s health ministry announced it would spend 193 billion won (152 million dollars) to secure vaccines against swine flu for 13 million people — more than a quarter of the population.

Scrub tech may have exposed thousands to hepatitis (AP)

Friday, July 3rd, 2009

AP – A former surgery technician may have exposed thousands of Colorado patients to hepatitis C when she swapped her own dirty syringes for ones filled with a powerful narcotic, federal authorities said Thursday.

Increasing Alcohol Use Tied to More Hospitalization (HealthDay)

Friday, July 3rd, 2009

HealthDay – WEDNESDAY, July 1 (HealthDay News) — The more alcohol men drink, the
more time they spend in a hospital, research from the United Kingdom has
found.

Health Tip: Straining the Hamstring (HealthDay)

Friday, July 3rd, 2009

HealthDay – (HealthDay News) — A hamstring injury can sideline an athlete
or exercise buff for quite a while.

Health Tip: Controlling Asthma (HealthDay)

Friday, July 3rd, 2009

HealthDay – (HealthDay News) — Medication used to control asthma may be
used every day, without the fear of becoming addicted, the American
Academy of Family Physicians says.

Monthly Pet Pill Could Kill Fleas, Ticks (HealthDay)

Friday, July 3rd, 2009

HealthDay – THURSDAY, July 2 (HealthDay News) —
Controlling ticks and fleas is drudgery for countless pet owners. Now,
researchers report they’re closer to developing a monthly pill that would
conveniently rid cats and dogs of these disease-carrying invaders.

Another Genetic Link to Testicular Cancer Is Found (HealthDay)

Friday, July 3rd, 2009

HealthDay – THURSDAY, July 2 (HealthDay News) — A second gene linked to
inherited testicular germ-cell cancer has been identified by scientists at
the U.S. National Institutes of Health.

Study Casts Doubt on Low IQ’s Role in Early Death (HealthDay)

Friday, July 3rd, 2009

HealthDay – THURSDAY, July 2 (HealthDay News) — Low IQ alone doesn’t
increase a person’s risk of early death, says a new study that challenges
findings suggested by previous research.

Clinical Trials Update: July 2, 2009 (HealthDay)

Friday, July 3rd, 2009

HealthDay – (HealthDay News) — Here are the latest clinical trials, courtesy
of CenterWatch and ClinicalConnection.com:

Multaq Sanctioned for Heart Rhythm Disorders (HealthDay)

Friday, July 3rd, 2009

HealthDay – THURSDAY, July 2 (HealthDay News) — Multaq (dronedarone) tablets
have been approved by the U.S. Food and Drug Administration to promote a
normal heart rhythm in people with atrial fibrillation or atrial flutter.
These conditions cause the heart to beat too quickly and can prevent it
from pumping blood correctly.